Feb 7, 2006
Spacelabs Healthcare Announces New Patient Monitoring Wireless Options For UltraviewSL Compact Monitors
Spacelabs Healthcare Announces New Patient Monitoring Wireless Options For UltraviewSL Compact Monitors
Spacelabs Healthcare Announces New Patient Monitoring Wireless Options For UltraviewSL Compact Monitors
The product has been designed to meet customer needs for ease of use and compatibility with global standards, the UltraviewSL 2400 wireless monitor is compliant with 802.11b, the WiFi standard that has gained broad acceptance within health care institutions worldwide. A field upgrade kit has also been released enabling existing UltraviewSL 2400 compact monitors to operate in a wireless environment. Wireless and telemetry products comprise the fastest growing segment of the patient monitoring market; a global market that is valued in excess of USD$2.3 billion annually by industry forecasters.
Spacelabs Healthcare CEO Deepak Chopra said, Developing a wireless network option for the UltraviewSL 2400 is an exciting step for the Company and demonstrates the continual review and advancement of our product portfolio to ensure we meet the needs of our customers. A wireless network capability is increasingly important for clinicians to access and document real-time patient information even during transport, helping them make critical decisions quickly and seamlessly. We believe this wireless monitor will be a significant new addition to our patient monitoring offering.
In patient transport, when surveillance of critically ill patients may be most challenging, wireless connectivity is particularly important. By employing wireless monitoring, vital signs data can be displayed and viewed on central monitors while patients are being moved, enhancing patient safety and emergency response capabilities. In addition, wireless connectivity allows for continued, seamless collection of patient data into Spacelabs Intesys Clinical Suite (ICS) of network applications, helping minimize interruptions in automated documentation.
The UltraviewSL 2400 wireless monitor provides a flexible solution that enables hospitals to augment the number of networked bedside monitors when extra capacity is needed. The new monitor has full network compatibility with all existing Spacelabs UltraviewSL, Ultraview and PCMS centrals and bedside monitors.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, pulse oximeters and sensors and bone densitometers selling to hospitals, clinics and physicians offices. Additionally, the company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted.
The company has established brand names in both medical devices and medical services such as Spacelabs, Blease and Dolphin. The company employs approximately 1,050 personnel in its 14 offices in UK, Canada, France, Germany, Finland, Singapore and the United States. The company conducts its manufacturing and R&D in India, the UK and the United States.
Spacelabs Healthcare is a subsidiary of OSI Systems, Inc., a US-based, Nasdaq listed company.
About OSI Systems, Inc.
OSI Systems Inc. is a Hawthorne, California based diversified global developer, manufacturer and seller of security and inspection systems, medical monitoring and anesthesia delivery products, and optoelectronic-based components, as well as a provider of engineering and manufacturing services. The company has more than 30 years of experience in electronics engineering and manufacturing and maintains offices and production facilities located in more than a dozen countries. OSI Systems implements a strategy of expansion by leveraging its electronics and contract manufacturing capabilities into selective end product markets through organic growth and acquisitions. For more information on OSI Systems Inc. or any of its subsidiary companies, visit www.osi-systems.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the companys expectations, goals or intentions about the future, including, but not limited to, statements regarding the sale of patient monitoring wireless options for the UltraviewSL. The actual results may differ materially from those described in or implied by any forward-looking statement. In particular, there can be no assurance that the product launch will occur as currently planned, that the product will work seamlessly with our products or the products of others, or that sales of the new product will be significant. Other important factors are set forth in our Securities and Exchange Commission filings. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
For Further Information
Spacelabs Healthcare, Inc
Jeremy Norton Director of Investor Relations
12525 Chadron Ave
Hawthorne CA 90250
(310) 349 2237
Spacelabs Healthcare Announces New Patient Monitoring Wireless Options For UltraviewSL Compact Monitors
Spacelabs Healthcare, Inc., a subsidiary of OSI Systems, Inc. (Nasdaq: OSIS), today announced its Monitoring Solutions Division has released a new wireless networking option for its UltraviewSL 2400 compact monitors. As part of the companys commitment to open standards and connectivity, Spacelabs has developed an innovative wireless solution that is capable of operating on a hospitals existing wireless infrastructure while coexisting with other wireless applications. The product will initially be launched in the US and Canada with planned worldwide distribution is schedule for the spring in 2006.The product has been designed to meet customer needs for ease of use and compatibility with global standards, the UltraviewSL 2400 wireless monitor is compliant with 802.11b, the WiFi standard that has gained broad acceptance within health care institutions worldwide. A field upgrade kit has also been released enabling existing UltraviewSL 2400 compact monitors to operate in a wireless environment. Wireless and telemetry products comprise the fastest growing segment of the patient monitoring market; a global market that is valued in excess of USD$2.3 billion annually by industry forecasters.
Spacelabs Healthcare CEO Deepak Chopra said, Developing a wireless network option for the UltraviewSL 2400 is an exciting step for the Company and demonstrates the continual review and advancement of our product portfolio to ensure we meet the needs of our customers. A wireless network capability is increasingly important for clinicians to access and document real-time patient information even during transport, helping them make critical decisions quickly and seamlessly. We believe this wireless monitor will be a significant new addition to our patient monitoring offering.
In patient transport, when surveillance of critically ill patients may be most challenging, wireless connectivity is particularly important. By employing wireless monitoring, vital signs data can be displayed and viewed on central monitors while patients are being moved, enhancing patient safety and emergency response capabilities. In addition, wireless connectivity allows for continued, seamless collection of patient data into Spacelabs Intesys Clinical Suite (ICS) of network applications, helping minimize interruptions in automated documentation.
The UltraviewSL 2400 wireless monitor provides a flexible solution that enables hospitals to augment the number of networked bedside monitors when extra capacity is needed. The new monitor has full network compatibility with all existing Spacelabs UltraviewSL, Ultraview and PCMS centrals and bedside monitors.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, pulse oximeters and sensors and bone densitometers selling to hospitals, clinics and physicians offices. Additionally, the company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted.
The company has established brand names in both medical devices and medical services such as Spacelabs, Blease and Dolphin. The company employs approximately 1,050 personnel in its 14 offices in UK, Canada, France, Germany, Finland, Singapore and the United States. The company conducts its manufacturing and R&D in India, the UK and the United States.
Spacelabs Healthcare is a subsidiary of OSI Systems, Inc., a US-based, Nasdaq listed company.
About OSI Systems, Inc.
OSI Systems Inc. is a Hawthorne, California based diversified global developer, manufacturer and seller of security and inspection systems, medical monitoring and anesthesia delivery products, and optoelectronic-based components, as well as a provider of engineering and manufacturing services. The company has more than 30 years of experience in electronics engineering and manufacturing and maintains offices and production facilities located in more than a dozen countries. OSI Systems implements a strategy of expansion by leveraging its electronics and contract manufacturing capabilities into selective end product markets through organic growth and acquisitions. For more information on OSI Systems Inc. or any of its subsidiary companies, visit www.osi-systems.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the companys expectations, goals or intentions about the future, including, but not limited to, statements regarding the sale of patient monitoring wireless options for the UltraviewSL. The actual results may differ materially from those described in or implied by any forward-looking statement. In particular, there can be no assurance that the product launch will occur as currently planned, that the product will work seamlessly with our products or the products of others, or that sales of the new product will be significant. Other important factors are set forth in our Securities and Exchange Commission filings. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
For Further Information
Spacelabs Healthcare, Inc
Jeremy Norton Director of Investor Relations
12525 Chadron Ave
Hawthorne CA 90250
(310) 349 2237